First case report of oral histoplasmosis in a patient receiving Secukinumab (Cosentyx): opportunistic infections as complication of emerging immunomodulatory therapies

This publication has 29 references indexed in Scilit:

• Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis
  Inflammopharmacology, 2022
• The occurrence of histoplasmosis in Brazil: A systematic review
  International Journal of Infectious Diseases, 2019
• Secukinumab: A Review in Ankylosing Spondylitis
  Drugs, 2019
• Oral Histoplasmosis
  Head and Neck Pathology, 2017
• Secukinumab: A Review in Psoriatic Arthritis
  Drugs, 2016
• Fungal Infections and New Biologic Therapies
  Current Rheumatology Reports, 2016
• Revisiting old friends: Developments in understanding Histoplasma capsulatum pathogenesis
  Journal of Microbiology, 2016
• Secukinumab: A Review in Moderate to Severe Plaque Psoriasis
  American Journal of Clinical Dermatology, 2015
• Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
  Journal of Crohn's and Colitis, 2014
• Primary localized histoplasmosis with lesions restricted to the mouth in a Chinese HIV-negative patient
  International Journal of Infectious Diseases, 2010